Riskpilot← Back to searchSign inGet full accessBJERRE ANDERSEN HOLDING ApS
APSActiveCVR 36449861Themsvej 26Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2014— employees
Revenue 2024
DKK 0
EBITDA margin
—
-70% vs 2023
Equity ratio
60.5%
Financial strength
Net profit 2024
DKK -65K
-137% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -36K | -70% |
| Net profit | DKK -65K | -137% |
| Total assets | DKK 2M | -25% |
| Equity | DKK 1,2M | -5% |
| Employees | — | — |
Legal name
BJERRE ANDERSEN HOLDING ApS
CVR number
36449861
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
25. november 2014
Share capital
DKK 580.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet forpligtes ved aftaler, som indgås på selskabets vegne af den samlede bestyrelse eller af en direktør i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive virksomhed med investering i selskaber og hermed forbundet virksomhed.
Address
Themsvej 26
Phone
+4540460059
Email
pkma@bjerreandersen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | — | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1 | 0 | -6 | -12 | 0 | -7 | -3 | 0 | -21 | -36 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1 | 0 | -6 | -12 | 0 | -7 | -3 | 0 | -21 | -36 |
| Net financials | 0 | 0 | 0 | 554 | 0 | 0 | 0 | -0 | 239 | -30 |
| Profit before tax | -1 | 0 | -6 | 542 | 0 | -7 | -3 | -0 | 218 | -66 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 42 | -1 |
| Net profit | -1 | 0 | -6 | 542 | 0 | -7 | -3 | -0 | 176 | -65 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 500 | 500 | 574 | 1.115 | 1.150 | 1.108 | 1.105 | 1.438 | 2.678 | 2.010 |
| Equity | 499 | 499 | 573 | 1.115 | 1.115 | 1.108 | 1.105 | 1.105 | 1.281 | 1.216 |
| Long-term debt | 0 | 0 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 333 | 1.397 | 793 |
| Total debt | 1 | 1 | 1 | 0 | 35 | 0 | 0 | 333 | 1.397 | 793 |
EBITDA margin
-3569200.0%
This company
15.8%
Market median
-22589973% vs market
20152024
Equity ratio
60.5%
This company
38.2%
Market median
+58% vs market
20152024
Return on equity
-5.3%
This company
18.4%
Market median
-129% vs market
20152024
Net profit margin
-6454600.0%
This company
8.1%
Market median
-79686520% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-11-25 – 2015-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.3% | 33.3% | 2014 | |
| Individual | 20.0% | 20.0% | 2014 | |
| Individual | 20.0% | 20.0% | 2014 | |
| Individual | 15.0% | 15.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BJERRE ANDERSEN HOLDING ApS 
Cystotech Invest II ApSBoard members of BJERRE ANDERSEN HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|